A novel diagnostics technology that reads gene expression patterns in the immune system to distinguish bacterial infections from viral infections and determines the severity within minutes will receive advanced development support from the HHS...Full Release
MedicalCountermeasures.gov can help you keep up-to-date on the latest developments in federal medical countermeasures activities, with information on public meetings and conferences, procurement and grant opportunities, strategies, reports, federal guidance on the development of medical countermeasures, and other announcements.
Provides links to information about public meetings, both upcoming and past, on issues pertaining to public health threats, both naturally occurring and manmade. Also included are links to online Meeting Libraries, such as the NIH Videocasting site.Learn More
Procurements and Grants
Provides links to relevant federal guidance on issues related to the development medical countermeasures, including information on Emergency Use Authorization, the Animal Efficacy Rule, and the Select Agent Rule.
Federal Business Opportunities (FedBizOpps) is the single government point-of-entry (GPE) for Federal government procurement opportunities over $25,000. Commercial vendors seeking Federal markets for their products and services can search, monitor and retrieve opportunities solicited by the entire Federal contracting community through FedBizOpps.Learn More
Provides links to relevant federal guidance on issues related to the development medical countermeasures, including information on Emergency Use Authorization, the Animal Efficacy Rule, and the Select Agent Rule.Learn More
Strategies and Reports
Provides links to sources of information useful to those involved in the research, development, and acquisition of medical countermeasures products, including Project Bioshield, and Public Health Emergency Medical Countermeasures Enterprise.Learn More
The Federal Government has launched several major initiatives intended to accelerate basic research and development of vaccines, therapeutics, and diagnostics for naturally occurring and manmade threats.Learn More
Latest news releases related to medical countermeasures
OPPORTUNITIES TO PARTNER WITH BARDA
To advance the development of a test that may be able to diagnose sepsis in less than 10 minutes, the U.S. Department of Health and Human Services (HHS) will partner with Cytovale of San Francisco.Full Release
With diagnostic tests based on machine-learning algorithms, patients with sepsis in hospital emergency departments, intensive care units and other hospital settings could be identified sooner than they currently are, and now HHS will work with Beckman Coulter Diagnostics of Brea, California, to develop such tools.Full Release